You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at S&P Capital IQ Pro or S&P Capital IQ .
Biostage to delist from Nasdaq
S&P Capital IQ Pro | Unrivaled Sector Coverage
S&P Capital IQ Pro | Powering Your Edge
Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud
Investment Research Analysts Providing Greater Coverage on Inflation
Biostage Inc. said Nasdaq will complete the delisting process for its common stock, after it failed to regain compliance with the rules.
The biotech company receive the notice of suspension in October. Concurrently, it started trading on the OTCQB marketplace under the symbol BSTG.
Biostage said the Nasdaq delisting will not affect its OTCQB marketplace listing.